| AQUIPTA 10 mg tablets EU/1/23/1750/001-002 |
Atogepant monohydrate |
AbbVie Deutschland GmbH & Co. KG |
— |
| AQUIPTA 60 mg tablets EU/1/23/1750/003-004 |
Atogepant monohydrate |
AbbVie Deutschland GmbH & Co. KG |
— |
| Constella 290 micrograms hard capsules EU/1/12/801/001-004 |
Linaclotide |
AbbVie Deutschland GmbH & Co. KG |
— |
| Ganfort 0.3 mg/ml + 5 mg/ml eye drops, solution EU/1/06/340/001-002 |
Bimatoprost, Timolol |
AbbVie Deutschland GmbH & Co. KG |
— |
| Humira 20 mg solution for injection in pre-filled syringe EU/1/03/256/022 |
Adalimumab |
AbbVie Deutschland GmbH & Co. KG |
— |
| Humira 40 mg/0.8 ml solution for injection EU/1/03/256/1-10 |
Adalimumab |
AbbVie Deutschland GmbH & Co. KG |
— |
| Humira 80 mg solution for injection in pre-filled syringe EU/1/03/256/020 |
Adalimumab |
AbbVie Deutschland GmbH & Co. KG |
— |
| Kaletra EU/1/01/172/4-5,7-8 |
Lopinavir, Ritonavir |
AbbVie Deutschland GmbH & Co. KG |
— |
| Kaletra (80 mg + 20 mg)/ml oral solution EU/1/01/172/003 |
Ritonavir, Lopinavir |
AbbVie Deutschland GmbH & Co. KG |
— |
| Kaletra 100 mg/25 mg film-coated tablets EU/1/01/172/006 |
Ritonavir, Lopinavir |
AbbVie Deutschland GmbH & Co. KG |
— |
| Lumigan 0.1 mg/ml eye drops, solution EU/1/02/205/3-4 |
Bimatoprost |
AbbVie Deutschland GmbH & Co. KG |
— |
| Lumigan 0.3 mg/ml eye drops, solution EU/1/02/205/001-2 |
Bimatoprost |
AbbVie Deutschland GmbH & Co. KG |
— |
| Maviret 100 mg/40 mg film-coated tablets EU/1/17/1213/001 |
Pibrentasvir, Glecaprevir |
AbbVie Deutschland GmbH & Co. KG |
— |
| Maviret 50 mg/20 mg coated granules in sachet EU/1/17/1213/003 |
Glecaprevir, Pibrentasvir |
AbbVie Deutschland GmbH & Co. KG |
— |
| Norvir 100 mg film-coated tablets EU/1/96/016/005-006 |
Ritonavir |
AbbVie Deutschland GmbH & Co. KG |
— |
| Norvir 100 mg powder for oral suspension EU/1/96/016/009 |
Ritonavir |
AbbVie Deutschland GmbH & Co. KG |
— |
| OZURDEX 700 micrograms intravitreal implant in applicator EU/1/10/638/001 |
Dexamethasone |
AbbVie Deutschland GmbH & Co. KG |
— |
| RINVOQ 15 mg prolonged-release tablets EU/1/19/1404/001-005 |
UPADACITINIB, Upadacitinib Hemihydrate |
AbbVie Deutschland GmbH & Co. KG |
— |
| RINVOQ 30 mg prolonged-release tablets EU/1/19/1404/006-009 |
Upadacitinib Hemihydrate |
AbbVie Deutschland GmbH & Co. KG |
— |
| RINVOQ 45 mg prolonged-release tablets EU/1/19/1404/010-011 |
Upadacitinib Hemihydrate |
AbbVie Deutschland GmbH & Co. KG |
— |
| Skyrizi 150 mg Solution for injection EU/1/19/1361/003 |
RISANKIZUMAB |
AbbVie Deutschland GmbH & Co. KG |
— |
| Skyrizi 150 mg Solution for injection EU/1/19/1361/002 |
RISANKIZUMAB |
AbbVie Deutschland GmbH & Co. KG |
— |
| Skyrizi 180 mg Solution for injection EU/1/19/1361/007 |
RISANKIZUMAB |
AbbVie Deutschland GmbH & Co. KG |
— |
| Skyrizi 180 mg solution for injection in pre-filled syringe EU/1/19/1361/008-009 |
RISANKIZUMAB |
AbbVie Deutschland GmbH & Co. KG |
— |
| Skyrizi 360 mg Solution for injection EU/1/19/1361/005 |
RISANKIZUMAB |
AbbVie Deutschland GmbH & Co. KG |
— |
| Skyrizi 55 mg solution for injection in pre-filled syringe EU/1/19/1361/010 |
RISANKIZUMAB |
AbbVie Deutschland GmbH & Co. KG |
— |
| Skyrizi 600 mg Concentrate for solution for injection EU/1/19/1361/004 |
RISANKIZUMAB |
AbbVie Deutschland GmbH & Co. KG |
— |
| Skyrizi 75 mg Solution for injection EU/1/19/1361/001 |
RISANKIZUMAB |
AbbVie Deutschland GmbH & Co. KG |
— |
| Skyrizi 90 mg Solution for injection EU/1/19/1361/006 |
RISANKIZUMAB |
AbbVie Deutschland GmbH & Co. KG |
— |
| Tepkinly 4 mg/0.8 ml solution for injection EU/1/23/1759/001 |
Epcoritamab |
AbbVie Deutschland GmbH & Co. KG |
— |
| Tepkinly 48 mg solution for injection EU/1/23/1759/002 |
Epcoritamab |
AbbVie Deutschland GmbH & Co. KG |
— |
| Venclyxto 10 mg film-coated tablets EU/1/16/1138/001-002 |
Venetoclax |
AbbVie Deutschland GmbH & Co. KG |
— |
| Venclyxto 100 mg film-coated tablets EU/1/16/1138/005-007 |
Venetoclax |
AbbVie Deutschland GmbH & Co. KG |
— |
| Venclyxto 50 mg film-coated tablets EU/1/16/1138/003-004 |
Venetoclax |
AbbVie Deutschland GmbH & Co. KG |
— |
| Xydalba EU/1/14/986/001 |
Dalbavancin hcl |
AbbVie Deutschland GmbH & Co. KG |
— |